Some Incomplete Notes from the MNKD Conference Call | MNKD Message Board Posts

MannKind Corporation

  MNKD website

MNKD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  16327 of 16665  at  1/4/2019 12:17:44 PM  by

tocentsworth

The following message was updated on 1/4/2019 4:17:13 PM.

Some Incomplete Notes from the MNKD Conference Call

1. Focusing sales now on 30 states rather than 44
    (Will cut "drive time" between sales appointments)
2. TV ads will be coordinated through CMI, for better value
3. Technosphere pipeline of 7 more molecules, with a high concentration on 4
    (Will be unique, and must be therapeutic)
4. Prior authorizations cut from 70-80% on Mike C.'s arrival to a single digit %
    (3 yr. Contracts of PBMs starting to expire)
5. Payor coverage getting better over time, especially with recent mergers 
   (CVS and Aetna, CIGNA and Express Scripts (?))
6. Recent share offering should take MNKD through 2019, especially if share price is 
    above $1.60, for warrant exercise
7. New Afrezza "direct purchase" plan which will avoid middlemen, for those who can
    pay cash.
 
 
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 5     Views: 181
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...